Interleukin-17- and interleukin-22-secreting myelin-specific CD4+T cells resistant to corticoids are related with active brain lesions in multiple sclerosis patients
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Interleukin-17- and interleukin-22-secreting myelin-specific CD4+T cells resistant to corticoids are related with active brain lesions in multiple sclerosis patients
Authors
Keywords
-
Journal
IMMUNOLOGY
Volume 147, Issue 2, Pages 212-220
Publisher
Wiley
Online
2015-11-02
DOI
10.1111/imm.12552
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Expression of GM-CSF in T Cells Is Increased in Multiple Sclerosis and Suppressed by IFN-β Therapy
- (2015) Javad Rasouli et al. JOURNAL OF IMMUNOLOGY
- Dopamine favors expansion of glucocorticoid-resistant IL-17-producing T cells in multiple sclerosis
- (2014) Thais B. Ferreira et al. BRAIN BEHAVIOR AND IMMUNITY
- Pro-inflammatory human Th17 cells selectively express P-glycoprotein and are refractory to glucocorticoids
- (2014) Radha Ramesh et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Th22 cells are expanded in multiple sclerosis and are resistant to IFN-β
- (2014) Simona Rolla et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Low sensitivity to glucocorticoid inhibition of in vitro Th17-related cytokine production in multiple sclerosis patients is related to elevated plasma lipopolysaccharide levels
- (2013) Bruna Teixeira et al. CLINICAL IMMUNOLOGY
- IL-22 secreting CD4+ T cells in the patients with neuromyelitis optica and multiple sclerosis
- (2013) Wen Xu et al. JOURNAL OF NEUROIMMUNOLOGY
- Moving toward earlier treatment of multiple sclerosis: Findings from a decade of clinical trials and implications for clinical practice
- (2013) Mark S. Freedman et al. Multiple Sclerosis and Related Disorders
- 2010 McDonald criteria for diagnosing pediatric multiple sclerosis
- (2012) Yair Sadaka et al. ANNALS OF NEUROLOGY
- Dynamic Development of Glucocorticoid Resistance during Autoimmune Neuroinflammation
- (2012) Stefan M. Gold et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- RORγt drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation
- (2011) Laura Codarri et al. NATURE IMMUNOLOGY
- The natural history of multiple sclerosis, a geographically based study 10: relapses and long-term disability
- (2010) Antonio Scalfari et al. BRAIN
- IL-22RA2 Associates with Multiple Sclerosis and Macrophage Effector Mechanisms in Experimental Neuroinflammation
- (2010) A. D. Beyeen et al. JOURNAL OF IMMUNOLOGY
- Differences in the progression of primary progressive multiple sclerosis in Brazilians of African descent versus white Brazilian patients
- (2010) Claudia Cristina Ferreira Vasconcelos et al. Multiple Sclerosis Journal
- Does race matter for multiple sclerosis?
- (2010) B. Cree et al. NEUROLOGY
- Rapid disease course in African Americans with multiple sclerosis
- (2010) I. Kister et al. NEUROLOGY
- Preferential recruitment of interferon-γ-expressing TH17 cells in multiple sclerosis
- (2009) Hania Kebir et al. ANNALS OF NEUROLOGY
- Phenotypical and functional characterization of T helper 17 cells in multiple sclerosis
- (2009) Verena Brucklacher-Waldert et al. BRAIN
- Multiple sclerosis susceptibility alleles in African Americans
- (2009) B A Johnson et al. GENES AND IMMUNITY
- C-C chemokine receptor 6–regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE
- (2009) Andrea Reboldi et al. NATURE IMMUNOLOGY
- Patients with multiple sclerosis resisted to glucocorticoid therapy: abnormal expression of heat-shock protein 90 in glucocorticoid receptor complex
- (2008) M Matysiak et al. Multiple Sclerosis Journal
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started